CIENCIAS FARMACÉUTICAS
Department
Hospital Universitario Reina Sofia
Córdoba, EspañaPublications in collaboration with researchers from Hospital Universitario Reina Sofia (15)
2024
-
Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry
Therapeutic Advances in Gastroenterology, Vol. 17
-
Serum and Urine Metabolomic Profiling of Newly Diagnosed Treatment-Naïve Inflammatory Bowel Disease Patients
Inflammatory Bowel Diseases, Vol. 30, Núm. 2, pp. 167-182
2023
-
Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety
American Journal of Gastroenterology, Vol. 118, Núm. 7, pp. 1237-1247
2022
-
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study
Inflammatory bowel diseases, Vol. 28, Núm. 11, pp. 1725-1736
-
Real-world use of mycophenolate mofetil in inflammatory bowel disease: Results from the ENEIDA registry
Digestive and Liver Disease, Vol. 54, Núm. 5, pp. 635-641
-
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab
Journal of Clinical Medicine, Vol. 11, Núm. 15
2021
-
Impact of biological agents on postsurgical complications in inflammatory bowel disease: A multicentre study of geteccu
Journal of Clinical Medicine, Vol. 10, Núm. 19
-
Pharmacogenetics of trough serum anti-TNF levels in paediatric inflammatory bowel disease
British Journal of Clinical Pharmacology, Vol. 87, Núm. 2, pp. 447-457
2020
-
Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn’s disease
United European Gastroenterology Journal, Vol. 8, Núm. 9, pp. 1056-1066
2019
-
Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study
Journal of Crohn's & colitis, Vol. 13, Núm. 12, pp. 1492-1500
2006
-
Population pharmacokinetics of high-dose methotrexate in children with acute lymphoblastic leukaemia
Clinical Pharmacokinetics, Vol. 45, Núm. 12, pp. 1227-1238
1998
-
Factores clínicos que influyen en la detección de transcrites BCR-ABL después del trasplante de médula ósea alogénico por leucemia mieloide crónico
Medicina Clinica, Vol. 111, Núm. 11, pp. 405-409
1997
-
Chimerism analysis in long-term survivor patients after bone marrow transplantation for severe aplastic anemia
Haematologica, Vol. 82, Núm. 5, pp. 588-591
1995
-
Molecular heterogeneity in childhood precursor b acute lymphoblastic leukemia with immunoglobulin heavy chain gene in germline configuration
Leukemia and Lymphoma, Vol. 20, Núm. 1-2, pp. 157-160
-
Optimal timing of granulocyte colony-stimulating factor (G-CSF) administration after bone marrow transplantation - A prospective randomized study
Annals of Hematology, Vol. 71, Núm. 2, pp. 65-70